NB

Nileshkumar Batukbhai Vaghani

Active Director Designated Partner DIN 10198116
DIN 10198116 First appointment Jun 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nileshkumar Batukbhai Vaghani

Data last updated:

Nileshkumar Batukbhai Vaghani is a Designated Partner at Chemneal Pharmaceuticals Llp (since 2023). The company operates in Chemicals.

DIN 10198116
Primary Designation Designated Partner
Industry Chemicals
First Appointment 14 Jun 2023
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Jun 20232021Active

Board colleagues of Nileshkumar Batukbhai Vaghani

Directorship timeline

Open interactive timeline →
Chemneal Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Nileshkumar Batukbhai Vaghani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nileshkumar Batukbhai Vaghani

Nileshkumar Batukbhai Vaghani currently holds 1 directorship: Chemneal Pharmaceuticals Llp (Designated Partner, since 14 Jun 2023).

Nileshkumar Batukbhai Vaghani was first appointed on 14 Jun 2023 as Designated Partner at Chemneal Pharmaceuticals Llp.

The current boards of Nileshkumar Batukbhai Vaghani's companies include Chintan Manjibhai Vaghani (Chemneal Pharmaceuticals Llp), Hetalben Chintan Vaghani (Chemneal Pharmaceuticals Llp), Shaileshkumar Batukbhai Vaghani (Chemneal Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available